Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1242.00
-3.50 (-0.28%)
< Home < Back

Dr. Reddy's gets 3 observations from USFDA for API Manufacturing Plant in Telangana

Date: 06-03-2020

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy's Laboratories’ API Manufacturing Plant-5 at Miryalaguda, Nalgonda District, Telangana. The company has been issued a Form 483 with 3 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.